OTC

05/08/2013 - 11:24am

There is as much as $10 billion in branded pharmaceutical sales that could make the switch from prescription-only to over-the counter in the next five years, suggested Joseph Papa, Perrigo chairman, CEO and president, to analysts on Tuesday.

05/08/2013 - 10:51am

The Council for Responsible Nutrition and the Natural Products Association announced they have met with the entire freshman class of the 113th Congress, including 83 offices in the House of Representatives and 14 offices in the Senate, as part of their educational efforts to ensure that newly elected members of Congress have accurate information about dietary supplements and their role in good health.

05/08/2013 - 10:12am

A pharmacist in Queens has received accolades for giving out vitamins to children whose families can't afford them.

05/07/2013 - 11:48am

Fitbit on Monday released the Fitbit Flex, the only activity tracking wristband on the market to sync wirelessly on-the-go via Bluetooth 4.0 to select iOS and Android devices.

05/07/2013 - 11:02am

Stayhealthy on Monday named Iz-On Media the company's exclusive advertising sales, content and programming representative for the Stayhealthy HealthCenter Kiosk Network.

05/07/2013 - 10:44am

According to a recent Prevention survey, 74% of women are interested in knowing more about how their digestive system works, but almost half surveyed believe that digestive health is a taboo subject people are uncomfortable discussing.

05/06/2013 - 1:41pm

The five associations representing the dietary supplement industry on Monday requested that the Food and Drug Administration issue revised guidance on new dietary ingredient notifications, with a specific focus on the information to be included to identify the new dietary ingredient.

05/06/2013 - 9:51am

Swiss Precision Diagnostics unveiled the new Clearblue Advanced Pregnancy Test with Weeks Estimator at the 61st Annual Clinical Meeting of the American Congress of Obstetricians and Gynecologists here.

05/06/2013 - 9:07am

The Food and Drug Administration may soon find itself in another Plan-B-generated quandary — the complications around granting a three-year marketing exclusivity for a medicine that is both prescription-only and over-the-counter, according to an FDA Law Blog posted Sunday by Hyman, Phelps & McNamara.

© 2013 Drug Store News. All Rights Reserved.